Document is current
Any future updates will be listed below
-
Authors
Hennessy, Elizabeth J.
van Solingen, Coen
Scacalossi, Kaitlyn R.
Ouimet, Mireille
Afonso, Milessa S.
Prins, Jurrien
Koelwyn, Graeme J.
Sharma, Monika
Ramkhelawon, Bhama
Carpenter, Susan
Busch, Albert
Chernogubova, Ekaterina
Matic, Ljubica Perisic
Hedin, Ulf http://orcid.org/0000-0001-9212-3945
Maegdefessel, Lars http://orcid.org/0000-0001-5228-2634
Caffrey, Brian E.
Hussein, Maryem A.
Ricci, Emiliano P. http://orcid.org/0000-0002-9789-5837
Temel, Ryan E.
Garabedian, Michael J.
Berger, Jeffrey S.
Vickers, Kasey C.
Kanke, Matthew
Sethupathy, Praveen
Teupser, Daniel
Holdt, Lesca M.
Moore, Kathryn J. http://orcid.org/0000-0003-2505-2547
- License Information
-
More Information
Article History
Received: 15 July 2018
Accepted: 16 October 2018
First Online: 3 December 2018
Competing interests
: K.J.M. and New York University hold a patent (US 9241950, status: issued 26 January 2016) on the use of miR-33 inhibitors to treat inflammation. All other authors have no competing interests.
